|
| |
| | | 59174 | | 17.11.2009 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 02 | Afinitor 5 mg | Tabletten | Tablets (Everolimus 5 mg) | L01XE10 | CI | | 03 | Afinitor 10 mg | Tabletten | Tablets (Everolimus 10 mg) | L01XE10 | CI | | 04 | Afinitor 2.5 mg | Tabletten | Tablets (Everolimus 2.5 mg) | L01XE10 | CI |
|
|
|
